Spinal fluid protein patterns recur in early Parkinson’s
The observational preprint compared healthy controls, people with possible early signs and people with untreated Parkinson’s in independent cohorts of 721 and 974 participants.
974 participants, independent replication
Limit: Protein differences do not amount to a validated clinical test
Stake: Authors work for Octave Bioscience. An author works for Ionis Pharmaceuticals.
Edited by Boris Djordjevic · AgingResearch.News
An observational study examined healthy controls, people with reduced smell or a sleep disorder involving dream-enacting behavior, and people with untreated Parkinson’s disease in cohorts of 721 and 974 participants. Researchers measured proteins in cerebrospinal fluid, which surrounds the brain and spinal cord.
In the discovery cohort, the reduced-smell and sleep-disorder groups differed from controls in no more than 16 proteins. Comparisons involving clinically apparent disease showed differences in up to 305 proteins. Across cohorts, a reproducible set of proteins involved in nerve-cell communication distinguished controls from Stage 3 disease, which involved slight impairment in functioning. The authors suggested that these patterns could help select participants for prevention and intervention trials based on disease biology.
Why it matters
Parkinson’s, an age-related disease, begins years before movement problems appear. Identifying its early biology could help researchers select participants for prevention trials.
Caveats
These observational findings do not establish a clinical test or show that the proteins cause disease. The preprint has not been peer-reviewed.
- Proteomics
- Parkinson's disease
- Dopaminergic dysfunction
- Hyposmia
- Isolated REM sleep behavior disorder
- Humans
The paper
University Medical Center Goettingen
medRxiv, Oct 20, 2026, Open access, CC BY, Preprint, not peer-reviewed
